Stock SIGA SIGA TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SIGA Technologies, Inc.

Equities

SIGA

US8269171067

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
8.79 USD +1.74% Intraday chart for SIGA Technologies, Inc. +5.40% +56.96%
Apr. 01 SIGA Technologies to Drive International Promotion for Oral TPOXX in Amended Deal With Meridian Medical MT
Apr. 01 SIGA Technologies, Inc. Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 562.7 557.4 537.5 398.1 625.2 -
Enterprise Value (EV) 1 562.7 454.2 438.7 248 458.6 432.9
P/E ratio 10.2 x 8.26 x 16 x 5.89 x 7.45 x 7.99 x
Yield - - 6.11% - - -
Capitalization / Revenue - 4.17 x 4.85 x 2.85 x 3.28 x 3.69 x
EV / Revenue - 3.4 x 3.96 x 1.77 x 2.41 x 2.56 x
EV / EBITDA - 5.1 x 9.91 x 2.95 x 4.39 x 4.49 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 77,400 74,116 73,024 71,092 71,123 -
Reference price 2 7.270 7.520 7.360 5.600 8.790 8.790
Announcement Date 3/4/21 3/3/22 3/2/23 3/12/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - 133.7 110.8 139.9 190.6 169.3
EBITDA 1 - 89.09 44.25 84.16 104.4 96.3
EBIT - 89.31 42.7 - - -
Operating Margin - 66.81% 38.55% - - -
Earnings before Tax (EBT) 1 - 89.31 44.13 87.78 108.4 100.7
Net income 56.34 69.45 33.9 - - -
Net margin - 51.96% 30.61% - - -
EPS 2 0.7100 0.9100 0.4600 0.9500 1.180 1.100
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - 0.4500 - - -
Announcement Date 3/4/21 3/3/22 3/2/23 3/12/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2023 Q1
Net sales 1 - - 8.323
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 1 - 33.04 -0.9183
Net margin - - -11.03%
EPS 2 0.0300 0.4500 -0.0100
Dividend per Share - - -
Announcement Date 8/4/22 11/3/22 5/4/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - 103 98.8 150 167 192
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - 0.05 - - 0.02 0.02
Capex / Sales - 0.04% - - 0.01% 0.01%
Announcement Date 3/4/21 3/3/22 3/2/23 3/12/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for SIGA Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SIGA TECHNOLOGIES, INC. Stock SIGA Technologies, Inc.
+56.96% 625M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SIGA Stock
  4. Financials SIGA Technologies, Inc.